Both in Biotechnology
Eikon Therapeutics vs Kyverna Therapeutics
Over the past year EIKN returned −47.3% and KYTX returned −5.9%; their daily moves had a correlation of 0.31.
EIKN −47.3% KYTX −5.9%Growth of $1, one year, split-adjusted
| Metric | EIKN | KYTX |
|---|---|---|
| Price | $7.91 | $6.84 |
| Market cap | $428.4M | $423.0M |
| Today | 0.00% | +0.29% |
| 1 month | −28.0% | −18.3% |
| 6 months | −18.3% | −9.8% |
| Year to date | — | −27.2% |
| 1 year | — | +12.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $531.2M | $174.4M |
| Dividend yield | — | — |
| Volatility (60d) | 83.6% | 65.9% |
| Short % of float | 20.5% | 23.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).